BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 89 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $107,000 | -42.8% | 1,800 | -40.0% | 0.01% | -40.0% |
| Q1 2019 | $187,000 | -61.9% | 3,000 | -63.0% | 0.01% | -66.7% |
| Q4 2018 | $491,000 | -13.4% | 8,100 | -16.5% | 0.03% | +7.1% |
| Q3 2018 | $567,000 | -8.4% | 9,700 | -22.4% | 0.03% | -20.0% |
| Q2 2017 | $619,000 | -24.2% | 12,500 | -16.1% | 0.04% | -25.5% |
| Q1 2017 | $817,000 | +1.1% | 14,900 | +2.8% | 0.05% | -6.0% |
| Q4 2016 | $808,000 | +197.1% | 14,500 | +113.2% | 0.05% | +177.8% |
| Q3 2016 | $272,000 | 0.0% | 6,800 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $272,000 | – | 6,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |